U.S. Markets closed
  • S&P Futures

    3,948.75
    +3.75 (+0.10%)
     
  • Dow Futures

    33,672.00
    +39.00 (+0.12%)
     
  • Nasdaq Futures

    11,580.00
    +14.00 (+0.12%)
     
  • Russell 2000 Futures

    1,815.80
    +1.70 (+0.09%)
     
  • Crude Oil

    74.10
    -0.15 (-0.20%)
     
  • Gold

    1,782.00
    -0.40 (-0.02%)
     
  • Silver

    22.26
    -0.07 (-0.31%)
     
  • EUR/USD

    1.0467
    -0.0002 (-0.0209%)
     
  • 10-Yr Bond

    3.5130
    -0.0860 (-2.39%)
     
  • Vix

    22.17
    +1.42 (+6.84%)
     
  • GBP/USD

    1.2132
    -0.0001 (-0.0121%)
     
  • USD/JPY

    137.1120
    +0.1520 (+0.1110%)
     
  • BTC-USD

    17,059.74
    +10.51 (+0.06%)
     
  • CMC Crypto 200

    402.69
    +0.88 (+0.22%)
     
  • FTSE 100

    7,521.39
    -46.15 (-0.61%)
     
  • Nikkei 225

    27,729.02
    -156.85 (-0.56%)
     

Biogen Soars 40% on Alzheimer’s Drug Trial. Mizuho Raises the Stock to Buy.

Biogen Soars 40% on Alzheimer’s Drug Trial. Mizuho Raises the Stock to Buy.

Mizuho analyst Salim Syed says there are enough data on the drug "that likely allows for regulatory approval.